Paramount executives have discussed settling an October suit from Trump. That, in itself, is bad news.

A decision by a federal judge last week is reviving the effort to limit access to mifepristone, opening a fresh round of litigation over a widely used drug that has grown in importance since the ...

The only judge based there is Matthew Kacsmaryk, a nominee of former President Donald Trump who previously ruled in favor of a challenge to the pill's approval. The states want the federal Food ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump's ...

However, the FDA has eased restrictions on the drug. U.S. District Judge Matthew Kacsmaryk, who was appointed by President Donald Trump during his first term, ruled last Thursday that three states ...

Trump-appointed Judge Matthew Kacsmaryk ruled on Thursday that Republican Attorneys General from Idaho, Kansas, and Missouri could continue the litigation in his Amarillo, Texas, courtroom. They have ...

US District Judge Matthew Kacsmaryk ruled that Missouri, Kansas and Idaho can move ahead with a lawsuit seeking to revamp prescribing and use of the drug. Kaczmaryk, of the Northern District of ...